HomeCAPS • OTCMKTS
Follow
Capstone Therapeutics Corp Common Stock
Previous close
$5.20
Year range
$4.90 - $20.00
Market cap
819.57K USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
.INX
0.11%
Financials
Income Statement
Revenue
Net income
(USD) | 2022info | Y/Y change |
---|---|---|
Revenue | 61.56M | -7.76% |
Operating expense | 12.54M | 7.35% |
Net income | 2.32M | -40.96% |
Net profit margin | 3.76 | -35.95% |
Earnings per share | — | — |
EBITDA | 4.23M | -15.69% |
Effective tax rate | 25.27% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | 2022info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.00K | -54.00% |
Total assets | 65.21M | 7.16% |
Total liabilities | 31.88M | 0.33% |
Total equity | 33.33M | — |
Shares outstanding | 157.61K | — |
Price to book | 0.10 | — |
Return on assets | 3.96% | — |
Return on capital | 4.17% | — |
Cash Flow
Net change in cash
(USD) | 2022info | Y/Y change |
---|---|---|
Net income | 2.32M | -40.96% |
Cash from operations | -2.89M | -177.60% |
Cash from investing | -173.00K | 81.42% |
Cash from financing | 3.04M | 210.68% |
Net change in cash | -27.00K | -154.00% |
Free cash flow | -3.72M | — |
About
Founded
1987
Headquarters
Website
Employees
53